Part 1: Overview current literature about Thrombotic Thrombocytopenic Purpura
The first patient described with thrombotic thrombocytopenic purpura (TTP) is a 16 year old girl that died within 2 weeks after disease onset. She struggled with petechial bleeding, pallor, fever, paralysis, hematuria and coma (Lämmle et al. 2005). From the autopsy in 1924 Doctor E. Moschcowitz described hyaline thrombosis of the terminal arterioles and capillaries and he suspected that a powerful agglutinative and hemolitic poison was responsible for the disease (Moschcowitz 1924; Moschcowiz 1925). Four decades after the first diagnosis, five general diagnostic criteria were established. The clinical and laboratory features are fever, haemolytic anemia, purpura or other bleeding, transient or permanent neurologic signs and renal disease (Amorosi and Ultmann 1966) and are still used as the diagnostic hallmarks.
…show more content…
Moake et al. detected the presence of unusually large von Willebrand factor (ULVWF) multimers in plasma of patients with TTP and suspected that the ULVWF mulitmers were responsible for platelet clumping in the microvasculature. Moreover, they hypothesised that there was a lack of a depolymerase for the ULVWF (Moake et al. 1982). From then on, the lack of ULVWF depolymerase or the VWF-cleaving protease (VWFcp) was known to be responsible for TTP and was further established from then on (Lämmle et al. 2005; Furlan 2004; Tsai 2004; Moake
IV bolus of unfractionated Heparin or Subcutaneous injection of low molecular weight heparin (LMWH) may be used to prevent the formation of new blood clots. Nursing consideration: Require regular monitoring of activated partial thromboplasitn time (aPTT) and needed frequent heparin dose changes (Brunner and Suddarth’s, et al, 2010: 765). Fibrinolytic therapy: This therapy is given to dissolve the thrombus in the artery and restore the blood flow. There are two fibrinolytic drugs which are streptokinase and Recombinant tissue plasminogen activators (r-TPA) which includes Alteplase, reteplase and tenecteplase (Brunner and Suddarth’s, et al, 2010: 772).
SYMPTOMS Symptoms of this condition include: • Diarrhea. This may be watery, bloody, or yellow or green in color. • Fever. • Fatigue. • Loss of appetite.
It was reported in 2 dogs (.3%) in the ATCA survey. VonWillebrand’s disease (VWD) refers to low levels of VonWillebrand’s factor (VWF) a glycoprotein that when complexed with Factor VIII is responsible for platelet adhesion. Type 1 VWD is characterized by low levels of VWF but all multimers of the factor are present. Affected dogs have increased bleeding time after surgery or trauma. A DNA test for VWD in the Australian terrier is available through Genetic Technologies (Australia).
A high fever, low blood pressure, vomiting, and rash are some symptoms that require a medical
Buerger 's disease is are rare disease also known as thromboangiitis obliterans. This rare disease causes acute inflammation and thrombosis in the arteries and veins found on the body 's upper and lower extremities. Buerger 's disease causes clotting in the vessels; the obstruction of the vessels affects the tissues of the body by limiting the blood distribution. Due to the lack of blood, the body experiences pain and loss of tissue which leads to skin ulcerations. If the disease is extremely advanced it may also affect other vessels in the body that are not in the arms and legs (Mutukuro, Vishnu & Suresh, Kalkunte 56).
If a patient does not have a rash that presents itself, they can undergo blood tests to diagnose this disease. The first blood test includes ELISA. This tests for the amount of antibodies in the blood that are against the Lyme disease bacteria. If this first blood test is positive the patient then undergoes a Western Blot (Centers for Disease). This includes running the blood the test the antibodies against proteins found on the Lyme disease bacteria.
Errors include introducing infection which was not previously present (Walters, 2003). The fluid was malodourous and purulent and external laboratory ascitic fluid analysis confirmed septic
Hematomas are a disorder of the body and can happen easily in the body after certain events. A hematoma is blood swelling and clotting inside of the tissues. What happens when a person develops a hematoma is that the wall of the blood vessel has been injured causing blood to seep out and clot. It can sometimes be easily seen, like under the nail, and other times it is internal, like in the organs, and can’t be seen. There are many different types of hematomas that can be seen in people.
Bernard-Soulier syndrome is an inherited platelet disorder caused by a defect in a gene responsible for a receptor that aids platelets in adhering to the lining of injured blood vessels. This disorder is characterized by thrombocytopenia and large nonfunctional platelets (Pham,2007). Patients often present initially with bleeding symptoms such as purpua, epistaxis, ecchymosis, bleeding of the gums, and menorrhagia (Lanza,2006). Diagnosis is further confirmed by platelet aggregation studies and flow cytometry. Treatment is mainly supportive, such as, the use of DDAVP to shorten bleeding times, with more serious hemorrhages being treated with platelet transfusions.
Pathophysiology of Hematuria Throughout the process of filtration by the kidneys, along with the help of the ureters, the bladder and urethral to expel urine from the body, there are many possibilities that abnormalities can develop that could compromise the healthy characteristics of the filtration process. Hematuria, for example, is the irregular presence of red blood cells in the urine due to dissected variations of trauma in the urinary tract. There are two types of causes of hematuria, the glomerular and nonglomerular cause. The glomerular cause is trauma within the nephrons of the kidneys, where red blood cells enter the urine stream from the glomerulus.
A look into the blood disorder which is Sepsis Introduction There are many blood disorders that can and may, cause higher instances of mortality. The author is going to look specifically into Sepsis. The cause and It’s development, symptoms which may present, tests undertaken to determine a diagnosis of Sepsis, the treatment of Sepsis, the presently recorded data of instance of Sepsis within healthcare and its impact. The author’s research will pertain to information sourced primarily online including journals and PDF documents; along with personal long term experience within a clinical setting.
These findings may suggest an additional mechanism for the shock symptoms observed in patients with C. perfringens septicemia. The hemolysin, or θ-toxin, targets cholesterol receptors in the cell membrane to form pores and subsequently hemolysis [52]. This toxin also plays a role in advancing tissue necrosis by downregulating polymorphonuclear leukocyte adhesion to endothelial cells
• High fever, especially in young or old people. • Disability- Those with very specific sensory problems like blindness or deafness often
Other patients can have a disorder that their blood clots to fast or incorrectly causing them to get blood clots. These type of patients get medication to decrease the blood clotting. Patients with these types of disorders need constant monitoring by the Hematology
Introduction Platelet play a major role in hemostasis together with intact clotting factors , so the patients with impaired hematopoiesis and with variety of disorder in platelets numbers and function has to provided life - saving supportive therapy as platelets transfusion .one of the duty as medical laboratory is to make the platelet available to patients by two different method as this topic will cover it ,one called apheresis (plateletpheresis) and the other is isolation of the platelet from a unit of donated blood , both platelet apheresis and WBD platelets are considered platelet product . Methods and materials Plateletpheresis (single donor) : Apheresis is a Greek word mean (to carry away ) plateletpheresis